Alerts
Modified Hours for Thanksgiving

In recognition of the upcoming Thanksgiving holiday, some of our offices will have modified hours over the long weekend. Check here for modified hours.

Skip Navigation

Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors

Brief Summary

Type:
Multiple Sites (Solid Tumors)

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT03245151

Study #:
CMH - ADVL1711

Start Date:
Sep 30, 2019

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03245151

View Complete Trial Details & Eligibility at ClinicalTrials.gov